Our Vision and Mission

For too long, people have lived with the fear and uncertainty of a cancer diagnosis, creating a sense of helplessness and hopelessness. We at Unum know that the only course of action, the only way to eliminate the fear and uncertainty of cancer is to improve the treatment paradigm. Our team comes to work each day driven by that opportunity and a sense of urgency to deliver novel cell therapies to not only treat but cure cancer and provide new hope to patients and their families.

Advancements in cancer therapies are helping to prolong the lives of patients, yet many cancers, especially solid tumors, remain out of reach. Unum’s new platform technologies, Bolt-On Chimeric Receptor (BOXR) and Antibody-Coupled T Cell Receptor (ACTR), engineer a patient’s own T cells to:

  • Overcome immunosuppression in the solid tumor microenvironment that would otherwise prevent T cells from functioning
  • Selectively target tumor antigens while preventing attacks on healthy cells
purpose icon
“Unum Therapeutics is pursuing a pioneering approach to treating cancer with the ultimate goal of making our cell therapies both potentially curative and broadly accessible for people with solid tumors. Our engineered cell therapies are designed to overcome cancer’s attack on our immune response.”
Chuck Wilson
Chief Executive Officer